相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease
Ana Ricobaraza et al.
HIPPOCAMPUS (2012)
The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation
Rebeca Martinez-Turrillas et al.
NEUROBIOLOGY OF DISEASE (2012)
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Albert Giralt et al.
MOLECULAR NEURODEGENERATION (2011)
Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay
Peter H. p Reinhart et al.
NEUROBIOLOGY OF DISEASE (2011)
Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease
Damian M. Cummings et al.
ASN NEURO (2010)
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
Austen J. Milnerwood et al.
NEURON (2010)
Influence of the NR3A subunit on NMDA receptor functions
Maile A. Henson et al.
PROGRESS IN NEUROBIOLOGY (2010)
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease
Rona K. Graham et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroprotection by the NR3A Subunit of the NMDA Receptor
Nobuki Nakanishi et al.
JOURNAL OF NEUROSCIENCE (2009)
Mutant Huntingtin Impairs Vesicle Formation from Recycling Endosomes by Interfering with Rab11 Activity
Xueyi Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
Shu-ichi Okamoto et al.
NATURE MEDICINE (2009)
Downregulation of NR3A-Containing NMDARs Is Required for Synapse Maturation and Memory Consolidation
Adam C. Roberts et al.
NEURON (2009)
A comparison of Huntington disease and Huntington disease-like 2 neuropathology
Dobrila D. Rudnicki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Janghoo Lim et al.
NATURE (2008)
Huntington disease models and human neuropathology: similarities and differences
Jean Paul G. Vonsattel
ACTA NEUROPATHOLOGICA (2008)
Huntingtin interacting proteins are genetic modifiers of neurodegeneration
Linda S. Kaltenbach et al.
PLOS GENETICS (2007)
Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease
Gary Lynch et al.
JOURNAL OF NEUROSCIENCE (2007)
Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain
Jeremy M. Van Raamsdonk et al.
NEUROBIOLOGY OF DISEASE (2007)
The corticostriatal pathway in Huntington's disease
Carlos Cepeda et al.
PROGRESS IN NEUROBIOLOGY (2007)
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice
Alejandro Lloret et al.
HUMAN MOLECULAR GENETICS (2006)
Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1
I Pérez-Otaño et al.
NATURE NEUROSCIENCE (2006)
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases
RA Bodner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
RK Graham et al.
NEUROBIOLOGY OF DISEASE (2006)
Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease
AJ Starling et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions
EJ Slow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice
NK Mazarakis et al.
JOURNAL OF NEUROSCIENCE (2005)
RNA association and nucleocytoplasmic shuttling by ataxin-1
S Irwin et al.
JOURNAL OF CELL SCIENCE (2005)
A syntaxin 1, Gαo, and N-type calcium channel complex at a presynaptic nerve terminal:: Analysis by quantitative immunocolocalization
Q Li et al.
JOURNAL OF NEUROSCIENCE (2004)
Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction
ZH Qin et al.
JOURNAL OF NEUROSCIENCE (2004)
A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease
H Goehler et al.
MOLECULAR CELL (2004)
Recycling endosomes supply AMPA receptors for LTP
M Park et al.
SCIENCE (2004)
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
JM Canals et al.
JOURNAL OF NEUROSCIENCE (2004)
Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation
G Schaffar et al.
MOLECULAR CELL (2004)
Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease
LJ Li et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Huntington's disease: a synaptopathy?
JY Li et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains
J Modregger et al.
HUMAN MOLECULAR GENETICS (2002)
Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain
HK Wong et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice
VC Wheeler et al.
HUMAN MOLECULAR GENETICS (2002)
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron et al.
NEURON (2002)
NMDA receptor function in mouse models of Huntington disease
C Cepeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
JA Bibb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
